{{Rsnum
|rsid=10152811
|Gene=AGBL1
|Chromosome=15
|position=86311359
|Orientation=plus
|GMAF=0.2355
|Gene_s=AGBL1,OR7E157P
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 62.9 | 25.8 | 11.3
| HCB | 81.0 | 19.0 | 0.0
| JPT | 86.4 | 11.4 | 2.3
| YRI | 48.4 | 40.3 | 11.3
| ASW | 0.0 | 0.0 | 0.0
| CHB | 81.0 | 19.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23400010
  |Trait=Thiazide-induced adverse metabolic effects in hypertensive patients
  |Title=Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans.
  |RiskAllele=A
  |Pval=8E-7
  |OR=18.81
  |ORtxt=[11.32-26.3] mg/dL decrease
  |OA=1
}}